文献速递膀胱癌与上尿路尿路上皮癌

膀胱癌变异组织学患者手术量与生存的关联

Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer.
PubMed 文献 · Urology · 2021-10-01

该研究基于美国国家癌症数据库2004—2016年数据,纳入在1301家医院治疗的23284例膀胱癌变异组织学患者,按医院年诊治量分层分析。结果显示高手术量医院与更早行根治性膀胱切除术、更多新辅助化疗及更优总生存相关,鳞癌、小细胞癌和肉瘤样癌亚型中该关联持续存在。

要点

  • 高手术量医院与膀胱癌变异组织学患者总生存改善相关。
  • 年诊治量>2例的医院仅占18.5%,>4例的仅占5.7%。
  • 高手术量医院更常对非肌层浸润病变早期行根治性膀胱切除术。

核心结论

  • 在高手术量中心管理变异组织学尿路上皮癌与总生存改善相关。

研究设计与样本

  • 回顾性队列研究,查询美国国家癌症数据库2004—2016年数据,纳入23284例膀胱癌变异组织学患者,分布于1301家医院。

主要发现

  • 医院年诊治量>2例者占18.5%(n=241),>4例者占5.7%(n=76)。
  • 医院手术量与早期根治性膀胱切除术(用于非肌层浸润病变)及新辅助化疗(用于肌层浸润病变)的使用正相关。
  • 多变量分析显示医院手术量增加与生存改善相关;按亚型分层后,鳞癌、小细胞癌和肉瘤样癌中该关联持续存在。

临床怎么用

  • 提示变异组织学膀胱癌的诊治可考虑向高手术量中心集中或增加其可及性。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the relationship between hospital volume and the management of bladder cancer variant histology. Variant histologies of bladder cancer are rare which limits the ability for providers to develop expertise however there is a clear hospital and/or surgeon-volume relationship for management of rare or complex surgical and/or medical diseases. METHODS: We queried the National Cancer Database from 2004-2016 for all cases of bladder cancer, identifying cases of variant histology. Our primary outcome was overall survival while secondary outcomes included identifying treatment patterns. Hospitals were stratified into those that managed ≤2, >2-4, >4-6, and ≥6 cases per year of variant histology. RESULTS: We identified 23,284 patients with bladder cancer of variant histology who were treated at 1301 hospitals. Few institutions had high volume experience with this disease: 18.5% (n = 241) treated >2 patients annually and 5.7% (n = 76) treated >4 cases annually. Hospital volume positively correlated with utilization of early radical cystectomy (RC) in non-muscle invasive disease and neoadjuvant chemotherapy in muscle-invasive disease. On multivariable analysis, increased hospital volume was associated with improved survival. After stratifying by sub-type, hospital volume continued to be associated with improved survival for squamous, small cell, and sarcomatoid cancers. CONCLUSION: Management of variant histology urothelial carcinoma at high-volume centers is associated with improved overall survival. The mechanisms of this are multifactorial, and future research should focus on improvement opportunities for low-volume hospitals, centralization of care, and/or increased access to care at high-volume centers.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Sui W, Hall ME, Barocas DA, et al. Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer. Urology. 2021. PMID: 34606878. doi:10.1016/j.urology.2021.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。